Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to reduce hospital admission and decrease time to
disposition through establishing an effective treatment protocol for AF and Atrial Flutter in
the Emergency Department of Spectrum Health Lakeland. Secondary outcome is to measure if oral
diltiazem is an effective HR controlling agent in AF RVR and Flutter.